LATEST NEWS

A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.